Literature DB >> 22906829

Performance of succinylacetone assays and their associated proficiency testing outcomes.

B W Adam1, E M Hall, N K Meredith, T H Lim, C A Haynes, V R De Jesus, W H Hannon.   

Abstract

BACKGROUND: Succinylacetone (SUAC) is the primary metabolic marker for hepatorenal tyrosinemia.
MATERIALS AND METHODS: We used results reported for dried-blood-spot proficiency testing (PT) specimens and hepatorenal tyrosinemia patients' newborn screening (NBS) samples to demonstrate analytic biases in SUAC recoveries and differences in presumptive clinical classifications.
RESULTS: SUAC recoveries from non-kit and NeoBase™ kit tandem mass spectrometry methods were markedly different. Kit users that set high cutoff values submitted discordant clinical assessments of "within normal limits" for PT specimens enriched with 10-15 μmol SUAC/L in blood. SUAC levels in tyrosinemia patients' NBS samples analyzed by NeoBase™ kit were lower than those in samples analyzed by non-kit methods.
CONCLUSIONS: From 2009 to 2011, analytic biases in SUAC recoveries were consistent. Discordant clinical assessments of PT specimens were associated with high cutoff values for NeoBase™ kit results. Method-related differences in SUAC concentrations of tyrosinemia patients' samples were consistent with those of PT specimens. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22906829      PMCID: PMC4557813          DOI: 10.1016/j.clinbiochem.2012.08.007

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  9 in total

1.  Newborn screening fact sheets.

Authors:  Celia I Kaye; Frank Accurso; Stephen La Franchi; Peter A Lane; Northrup Hope; Pang Sonya; Schaefer G Bradley; Lloyd-Puryear Michele A
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

2.  Newborn screening for hepatorenal tyrosinemia: Tandem mass spectrometric quantification of succinylacetone.

Authors:  Johannes Sander; Nils Janzen; Michael Peter; Stefanie Sander; Ulrike Steuerwald; Ute Holtkamp; Bernd Schwahn; Ertan Mayatepek; Friedrich K Trefz; Anibh M Das
Journal:  Clin Chem       Date:  2006-01-26       Impact factor: 8.327

3.  Newborn screening for Tyr-I: two years' experience of the New York State program.

Authors:  M A Morrissey; S Sunny; A Fahim; C Lubowski; M Caggana
Journal:  Mol Genet Metab       Date:  2011-03-01       Impact factor: 4.797

4.  The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005.

Authors:  D M Frazier; D S Millington; S E McCandless; D D Koeberl; S D Weavil; S H Chaing; J Muenzer
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

5.  Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots.

Authors:  Pierre Allard; André Grenier; Mark S Korson; Thomas H Zytkovicz
Journal:  Clin Biochem       Date:  2004-11       Impact factor: 3.281

6.  Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots.

Authors:  Coleman Turgeon; Mark J Magera; Pierre Allard; Silvia Tortorelli; Dimitar Gavrilov; Devin Oglesbee; Kimiyo Raymond; Piero Rinaldo; Dietrich Matern
Journal:  Clin Chem       Date:  2008-02-15       Impact factor: 8.327

7.  Preliminary proficiency testing results for succinylacetone in dried blood spots for newborn screening for tyrosinemia type I.

Authors:  Barbara W Adam; Timothy H Lim; Elizabeth M Hall; W Harry Hannon
Journal:  Clin Chem       Date:  2009-10-22       Impact factor: 8.327

8.  Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters.

Authors:  Donald H Chace; Timothy Lim; Christina R Hansen; Victor R De Jesus; W Harry Hannon
Journal:  Clin Chim Acta       Date:  2009-06-21       Impact factor: 3.786

9.  Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.

Authors:  David M S McHugh; Cynthia A Cameron; Jose E Abdenur; Mahera Abdulrahman; Ona Adair; Shahira Ahmed Al Nuaimi; Henrik Åhlman; Jennifer J Allen; Italo Antonozzi; Shaina Archer; Sylvia Au; Christiane Auray-Blais; Mei Baker; Fiona Bamforth; Kinga Beckmann; Gessi Bentz Pino; Stanton L Berberich; Robert Binard; François Boemer; Jim Bonham; Nancy N Breen; Sandra C Bryant; Michele Caggana; S Graham Caldwell; Marta Camilot; Carlene Campbell; Claudia Carducci; Sandra C Bryant; Michele Caggana; S Graham Caldwell; Marta Camilot; Carlene Campbell; Claudia Carducci; Rohit Cariappa; Clover Carlisle; Ubaldo Caruso; Michela Cassanello; Ane Miren Castilla; Daisy E Castiñeiras Ramos; Pranesh Chakraborty; Ram Chandrasekar; Alfredo Chardon Ramos; David Cheillan; Yin-Hsiu Chien; Thomas A Childs; Petr Chrastina; Yuri Cleverthon Sica; Jose Angel Cocho de Juan; Maria Elena Colandre; Veronica Cornejo Espinoza; Gaetano Corso; Robert Currier; Denis Cyr; Noemi Czuczy; Oceania D'Apolito; Tim Davis; Monique G de Sain-Van der Velden; Carmen Delgado Pecellin; Iole Maria Di Gangi; Cristina Maria Di Stefano; Yannis Dotsikas; Melanie Downing; Stephen M Downs; Bonifacio Dy; Mark Dymerski; Inmaculada Rueda; Bert Elvers; Roger Eaton; Barbara M Eckerd; Fatma El Mougy; Sarah Eroh; Mercedes Espada; Catherine Evans; Sandy Fawbush; Kristel F Fijolek; Lawrence Fisher; Leifur Franzson; Dianne M Frazier; Luciana R C Garcia; Maria Sierra García-Valdecasas Bermejo; Dimitar Gavrilov; Rosemarie Gerace; Giuseppe Giordano; Yolanda González Irazabal; Lawrence C Greed; Robert Grier; Elyse Grycki; Xuefan Gu; Fizza Gulamali-Majid; Arthur F Hagar; Lianshu Han; W Harry Hannon; Christa Haslip; Fayza Abdelhamid Hassan; Miao He; Amy Hietala; Leslie Himstedt; Gary L Hoffman; William Hoffman; Philis Hoggatt; Patrick V Hopkins; David M Hougaard; Kerie Hughes; Patricia R Hunt; Wuh-Liang Hwu; June Hynes; Isabel Ibarra-González; Cindy A Ingham; Maria Ivanova; Ward B Jacox; Catharine John; John P Johnson; Jón J Jónsson; Eszter Karg; David Kasper; Brenda Klopper; Dimitris Katakouzinos; Issam Khneisser; Detlef Knoll; Hirinori Kobayashi; Ronald Koneski; Viktor Kozich; Rasoul Kouapei; Dirk Kohlmueller; Ivo Kremensky; Giancarlo la Marca; Marcia Lavochkin; Soo-Youn Lee; Denis C Lehotay; Aida Lemes; Joyce Lepage; Barbara Lesko; Barry Lewis; Carol Lim; Sharon Linard; Martin Lindner; Michele A Lloyd-Puryear; Fred Lorey; Yannis L Loukas; Julie Luedtke; Neil Maffitt; J Fergall Magee; Adrienne Manning; Shawn Manos; Sandrine Marie; Sônia Marchezi Hadachi; Gregg Marquardt; Stephen J Martin; Dietrich Matern; Stephanie K Mayfield Gibson; Philip Mayne; Tonya D McCallister; Mark McCann; Julie McClure; James J McGill; Christine D McKeever; Barbara McNeilly; Mark A Morrissey; Paraskevi Moutsatsou; Eleanor A Mulcahy; Dimitris Nikoloudis; Bent Norgaard-Pedersen; Devin Oglesbee; Mariusz Oltarzewski; Daniela Ombrone; Jelili Ojodu; Vagelis Papakonstantinou; Sherly Pardo Reoyo; Hyung-Doo Park; Marzia Pasquali; Elisabetta Pasquini; Pallavi Patel; Kenneth A Pass; Colleen Peterson; Rolf D Pettersen; James J Pitt; Sherry Poh; Arnold Pollak; Cory Porter; Philip A Poston; Ricky W Price; Cecilia Queijo; Jonessy Quesada; Edward Randell; Enzo Ranieri; Kimiyo Raymond; John E Reddic; Alejandra Reuben; Charla Ricciardi; Piero Rinaldo; Jeff D Rivera; Alicia Roberts; Hugo Rocha; Geraldine Roche; Cheryl Rochman Greenberg; José María Egea Mellado; María Jesús Juan-Fita; Consuelo Ruiz; Margherita Ruoppolo; S Lane Rutledge; Euijung Ryu; Christine Saban; Inderneel Sahai; Maria Isabel Salazar García-Blanco; Pedro Santiago-Borrero; Andrea Schenone; Roland Schoos; Barb Schweitzer; Patricia Scott; Margretta R Seashore; Mary A Seeterlin; David E Sesser; Darrin W Sevier; Scott M Shone; Graham Sinclair; Victor A Skrinska; Eleanor L Stanley; Erin T Strovel; April L Studinski Jones; Sherlykutty Sunny; Zoltan Takats; Tijen Tanyalcin; Francesca Teofoli; J Robert Thompson; Kathy Tomashitis; Mouseline Torquado Domingos; Jasmin Torres; Rosario Torres; Silvia Tortorelli; Sandor Turi; Kimberley Turner; Nick Tzanakos; Alf G Valiente; Hillary Vallance; Marcela Vela-Amieva; Laura Vilarinho; Ulrika von Döbeln; Marie-Francoise Vincent; B Chris Vorster; Michael S Watson; Dianne Webster; Sheila Weiss; Bridget Wilcken; Veronica Wiley; Sharon K Williams; Sharon A Willis; Michael Woontner; Katherine Wright; Raquel Yahyaoui; Seiji Yamaguchi; Melissa Yssel; Wendy M Zakowicz
Journal:  Genet Med       Date:  2011-03       Impact factor: 8.822

  9 in total
  4 in total

1.  Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.

Authors:  Víctor R De Jesús; Barbara W Adam; Daniel Mandel; Carla D Cuthbert; Dietrich Matern
Journal:  Mol Genet Metab       Date:  2014-07-17       Impact factor: 4.797

2.  Hereditary tyrosinemia type Ⅰ: newborn screening, diagnosis and treatment.

Authors:  Yue Tang; Yuanyuan Kong
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

3.  A Rapid Screening Test on Dried Blood for the Neonatal Diagnosis of Tyrosinemia Type I.

Authors:  Farahnaz Bodaghkhan; Bita Geramizadeh; Abbas Abdollah Rajeh; Mahmoud Haghighat; Mohsen Dehghani; Naser Honar; Mojgan Zahmatkeshan; Mohammad-Hadi Imanieh
Journal:  Iran J Pediatr       Date:  2016-02-27       Impact factor: 0.364

Review 4.  Newborn screening for Tyrosinemia type 1 using succinylacetone - a systematic review of test accuracy.

Authors:  Chris Stinton; Julia Geppert; Karoline Freeman; Aileen Clarke; Samantha Johnson; Hannah Fraser; Paul Sutcliffe; Sian Taylor-Phillips
Journal:  Orphanet J Rare Dis       Date:  2017-03-09       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.